News

Lower Risk of Cardiovascular Events in Postmenopausal Women Taking Oral Estradiol Compared With Oral Conjugated Equine Estrogens

01.10.20131679

To compare the relative clinical cardiovascular safety of 2 commonly used oral estrogen drugs—conjugated equine estrogens (CEEs) and estradiol.

Elderly patient with heart failure and preserved ejection fraction: effects of ivabradine

30.09.20131899

Approximately half of patients with a diagnosis of heart failure have a normal left ventricular ejection fraction. This patients are usually older, female and with comorbidities such as hypertension, diabetes and renal failure.

Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes

27.09.20131972

The aim of the current study was to evaluate the diagnostic and intermediate-term prognostic impact of C-terminal portion of provasopressin (copeptin) in combination with troponin I.

Exercise training is safe after coronary stenting: a prospective multicentre study

26.09.20131765

Data on the safety of exercise training after coronary stenting are scarce.

Biomarker IDs Fibrotic Heart Failure

25.09.20131878

Galectin-3 (Gal-3), a biomarker for fibrosis, may have a role in identifying heart failure caused by cardiac amyloidosis, researchers suggested.

Association of Statin Use With CataractsA Propensity Score–Matched Analysis

24.09.20131885

Cataracts are a main cause of low vision; with the growing elderly population, the incidence of cataracts is likely to increase. Investigators have previously hypothesized that statin antioxidant effects may slow the natural aging process of the lens.

Infective Endocarditis in Children With Congenital Heart Disease Cumulative Incidence and Predictors

24.09.20131819

The American Heart Association guidelines for prevention of infective endocarditis (IE) in 2007 reduced the groups of congenital heart disease (CHD) patients for whom antibiotic prophylaxis was indicated.